Congenital infantile fibrosarcoma mimicking a cutaneous vascular lesion: a case report and review of the literature

Journal of Cutaneous Pathology

Volumn 44, Issue 2, 2017, Pages 193-200

  Enos, Tyler ^a   Hosler, Gregory A ^a,b   Uddin, Naseem ^a   Mir, Adnan ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b ProPath   (United States)

Author keywords

cutaneous; Infantile fibrosarcoma; soft tissue tumors; vascular

Indexed keywords

TUMOR MARKER;

CASE REPORT; DIFFERENTIAL DIAGNOSIS; FIBROSARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FOREARM; HEMANGIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEWBORN; SOFT TISSUE NEOPLASMS;

BIOMARKERS, TUMOR; DIAGNOSIS, DIFFERENTIAL; FIBROSARCOMA; FOREARM; HEMANGIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT, NEWBORN; MALE; SOFT TISSUE NEOPLASMS;

EID: 85006282681     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12854     Document Type: Review

References (29)

1. Soule EH, Pritchard DJ. Fibrosarcoma in infants and children a review of 110 cases. Cancer 1997; 40: 1711.
2. Orbach D, Rey A, Cechetto G, et al. Infantile fibrosarcoma: management based on the European experience. J Clin Oncol 2010; 28: 318.
3. Goldblum JR, Folpe AL, Weiss SW. Borderline and malignant fibroblastic/myofibroblastic tumors. In Goldblum JR, Folpe AL, Weiss SW, eds. Enzinger and Weiss's soft tissue tumors. Philadelphia: Saunders, 2014; 300.
4. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 1998; 18: 184.
5. McCahon E, Sorensen PHB, Davis JH, Rogers PC, Schultz KR. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy. Med Pediatr Oncol 2003; 40: 288.
6. Eguchi M, Eguchi-Ishimae M, Tojo A, et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood 1999; 93: 1355.
7. Anderson J, Gibson S, Sebire NJ. Expression of ETV6-NTRK in classical, cellular and mixed subtypes of congenital mesoblastic nephroma. Histopathology 2006; 48: 748.
8. Kanack M, Collins J, Fairbanks TJ, Gosman A. Congenital-infantile fibrosarcoma presenting as a hemangioma: a case report. Ann Plast Surg 2015; 74(Suppl. 1): S25.
9. Requena C, Miranda L, Cañete A, et al. Congenital fibrosarcomas imulating congenital hemangioma. Pediatr Dermatol 2008; 25: 141.
10. Hu Z, Chou PM, Jennings LJ, Arva NC. Infantile fibrosarcoma-a clinical and histologic mimicker of vascular malformations: case report and review of the literature. Pediatr Dev Pathol 2013; 16: 357.
11. Jain D, Kohli K. Congenital infantile fibrosarcoma: a clinical mimicker of hemangioma. Cutis 2012; 89: 61.
12. Bellfield EJ, Beets-Shay L. Congenital infantile fibrosarcoma of the lip. Pediatr Dermatol 2014; 31: 88.
13. Kerl K, Nowacki M, Leuschner I, Masjosthusmann K, Frühwald MC. Infantile fibrosarcoma – an important differential diagnosis of congenital vascular tumors. Pediatr Hematol Oncol 2012; 29: 545.
14. Kimura C, Kitamura T, Sugihara T. A case of congenital infantile fibrosarcoma of the right hand. J Dermatol 1998; 25: 735.
15. Tay YK, Morelli HG, Weston WL. Congenital palmar nodule in an infant. Pediatr Dermatol 1997; 14: 241.
16. Yan AC, Chamlin SL, Liang MG, et al. Congenital infantile fibrosarcoma: a masquerader of ulcerated hemangioma. Pediatr Dermatol 2006; 23: 330.
17. Cissé M, Machet L, Le Touze A, Machet MC, Lejars O, Lorette G. Infantile fibrosarcoma mimicking rapidly involuting congenital haemangioma (RICH). Ann Dermatol Venereol 2008; 135: 53.
18. Shetty AK, Yu LC, Gardner RV, Warrier RP. Role of chemotherapy in the treatment of infantile fibrosarcoma. Med Pediatr Oncol 1999; 33: 425.
19. Ainsworth KE, Chavhan GB, Gupta AA, Hopyan S, Taylor G. Congenital infantile fibrosarcoma: review of imaging features. Pediatr Radiol 2014; 44: 1124.
20. Carroll SJ, Nodit L. Spindle cell rhabdomyosarcoma: a brief diagnostic review and differential diagnosis. Arch Pathol Lab Med 2013; 137: 1155.
21. Mahana S, Tomar R, Agarwal A, Sharma D, Khurana N, Gupta R. Spindle-cell rhabdomyosarcoma of the thumb: rare site, rare tumor in a child. Diagn Cytopathol 2016; doi:10.1002/dc.23552. [Epub ahead of print].
22. Gopal M, Chahal G, Al-Rifai Z, Eradi B, Ninan G, Nour S. Infantile myofibromatosis. Pediatr Surg Int 2008; 24: 287.
23. Mentzel T, Dei Tos AP, Sapi Z, Kutzner H. Myopericytoma of skin and soft tissues: Clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol 2006; 30: 104.
24. Maire G, Fraitag S, Galmiche L, et al. A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans. Arch Dermatol 2007; 143: 203.
25. Cheah AL, Goldblum JR, Billings SD. Molecular diagnostics complementing morphology in superficial mesenchymal tumors. Semin Diagn Pathol 2013; 30: 95.
26. Blocker S, Koenig J, Ternberg J. Congenital fibrosarcoma. J Pediatr Surg 1987; 22: 665.
27. Loh ML, Ahn P, Perez-Atayde AR, Gebhardt MC, Shamberger RC, Grier HE. Treatment of infantile fibrosarcoma with neoadjuvant chemotherapy: results from the Dana-Farber Cancer Institute and Children's Hospital Boston. J Pediatr Hematol Oncol 2002; 24: 722.
28. Grohn ML, Borzi P, Mackay A, Suppiah R. Management of extensive congenital fibrosarcoma with preoperative chemotherapy. ANZ J Surg 2004; 74: 919.
29. Orbach D, Brennan B, De Paoli A, et al. Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience. Eur J Cancer 2016; 57: 1.